FDA issued a Warning Letter to BioReliance Corporation on 1/5/2009 for a previous inspection.
483 BioReliance Jul 2012

483 BioReliance Jul 2012

Rachel Harrington FDA$119.00 - Available Now

FDA investigators audited the BioReliance - Rockville, MD, United States facility and issued 4 inspectional observations (via FDA 483) on 03 Jul 2012.

Product details

  • Category: Animal Drugs & Feeds / Human Drugs
  • Number of Observations: 4
  • Inspection end: 03 Jul 2012
  • Location: Rockville, United States
  • FEI: 1122041
Add To Cart